Clinical Trials

Lymphoma, Large B-Cell, Diffuse

NCT05376722 2023-01-05

A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer

Neoadjuvant Therapy

NCT04869371 2022-12-29

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

75 enrolled

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

NCT04356430 2022-12-16

Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer

75 enrolled

Prostatic Neoplasms

NCT04810156 2022-12-14

I-HEP

60 enrolled

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

NCT05167175 2022-10-25

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Prostatic Neoplasms

NCT05200312 2022-03-11

ZR2-CHOP

36 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05156450 2021-12-14

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

100 enrolled

Burkitt Lymphoma

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

33 enrolled

Lymphoma, T-Cell, Peripheral

NCT00324467 2021-07-22

LYTPET

150 enrolled

Lymphoma, Non-Hodgkin

NCT04025593 2020-11-19

Biomarker Guided Treatment in DLBCL

128 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

134 enrolled

Lymphoma, T-Cell, Peripheral

NCT02918747 2020-01-28

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

100 enrolled

Lymphoma

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

54 enrolled

Lymphoma, T-Cell, Peripheral

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

50 enrolled

LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

NCT03617432 2018-09-04

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

114 enrolled

Neoplasms, Experimental

NCT03356912 2017-12-14

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

220 enrolled

Prostatic Neoplasms

NCT02753647 2017-11-14

Chidamide Plus R-CHOP in Elderly DLBCL

49 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03321890 2017-10-26

Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

102 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT01685125 2017-07-07

Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

96 enrolled

Prostatic Neoplasms

NCT02660762 2017-06-19

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

Other hematologic neoplasm

100 enrolled

Leukemia

NCT02792491 2016-06-09

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

57 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01005758 2014-01-10

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

180 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00005959 2013-12-04

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00195871 2013-11-07

Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma

LymphoidOther hematologic neoplasm

155 enrolled

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003262 2013-09-20

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

Hodgkin Disease, Lymphoma

NCT00896519 2013-08-02

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Lymphoma, Lymphoma, Follicular

NCT01009970 2011-10-13

Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma

50 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00946374 2009-07-27

HD-MCL2003

20 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

54 enrolled

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes

NCT00333008 2006-09-26

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

27 enrolled